Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study

Journal of Dermatological Treatment

Volumn 20, Issue 5, 2009, Pages 259-265

  Van Der Geer, Simone ^a   Krekels, Gertruud A M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

Actinic keratoses; ALA; Diclofenac; PDT

Indexed keywords

AMINOLEVULINIC ACID; DICLOFENAC; PLACEBO;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EROSION; ERYTHEMA; EVENING DOSAGE; FEMALE; FOLLOW UP; GEL; HAND; HUMAN; MALE; MORNING DOSAGE; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SWELLING; THICKNESS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; AMINOLEVULINIC ACID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; GELS; HAND DERMATOSES; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 75849118834     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630902882048     Document Type: Article

References (29)

1. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1 Pt 2):4-7.
2. Cockerell CJ. Pathology and pathobiology of the actinic (solar) keratosis. Br J Dermatol. 2003;149(suppl 66):34-6.
3. Cockerell CJ, Wharton Jr. New histopathological classifcation of actinic keratosis (incipient intraepidermal squamous cell carcinoma). J Drugs Dermatol. 2005;4:462-7.
4. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42(1 Pt 2):8-10.
5. Fu W, Cockerell CJ. The actinic (solar) keratosis. A 21st-century perspective. Arch Dermatol. 2003;139:66-70.
6. Anwar J, Wrone DA, Kimyai-asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinoma: Evidence and evolving classifcation schemes. Clin Dermatol. 2004;22:189-96.
7. Czarnecki D, Meehan CJ, Bruce F, Culjak G. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg. 2002;6:207-9.
8. Jorizzo JL. Current and novel treatment options for actinic keratosis. J Cutan Med Surg. 2004;8(supp 3):13-21.
9. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol. 2000;42(1 Pt 2):25-8.
10. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30:2 Pt 2264-71.
11. Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronan gel. Br J Dermatol. 2002;146:94-100.
12. Wolf JE, Taylor JR, Tschen E, Kang S. Topical 3% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40:709-13.
13. Del Rosso J, Walsh K. A randomized, single center, double-blind, placebo-controlled study to evaluate the safety and the efficacy of 3% diclofenac gel in the topical treatment of outpatients with actinic keratoses (clinical trial summary, data on file). Malvern, PA: Bioglan Pharma Inc; 2001.
14. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: Outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19:134-41.
15. Kauffmann R, Spelman L, Weightman W, Reifenberger J, Szeimies RM, Verhaeghe E, et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol. 2008;158:994-9.
16. Wang I. Photodynamic therapy and laser-based diagnostic studies of malignant tumours. LundSweden: Lund University; 1999.
17. Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995;133:282-8.
18. Oosten van EJ, Kuijpers DIM, Thissen MRTM. Different pain sensations in photodynamic therapy of nodular basal cell carcinoma. Results from a prospective trial and a review of literature. Photodiagn Photodyn Ther. 2006;3:61-8.
19. Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol. 2008;158:727-33.
20. Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR. Irradiance-dependent photobleaching and pain in δ-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clin Cancer res. 2008;14:4475-83.
21. Jarvis B, Figgitt DP. Topical 3% diclofenac in 2.5% hyaluronic acid gel. A review of its use in patients with actinic keratoses. Am J Clin Dermatol. 2003;4:203-13.
22. Carroll CL, Feldmann SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: Commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51:212-16.
23. Pirard D, Vereecken P, Melot C, Heenen M. Three percent of diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: A meta-analysis of the recent studies. Arch Dermatol Res. 2005;297:185-9.
24. Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracol and photodynamic therapy. J Drugs Dermatol. 2005:4(2):161-3.
25. Mastrolonardo M. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses. Clin Exp Dermatol. 2009;34:33-5.
26. Devirgilliis V, Panasiti V, Curzio m, Gobbi S, Rossi M, Roberti V, et al. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Dermatol Online J. 2008;14(2):25.
27. Winters U, Daayana S, Lear JT, Tomlinson AE, Elkord E, Stern PL, et al. Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia. Clin Cancer Res. 2008;14:5292-9.
28. Theelen T, Hoyng CB. Intravenous diclofenac as prophylactic treatment for verteporfin-associated low back pain. Eur J Ophthalmol. 2008;18:805-8.
29. Pece A, Vadala M, Manzi R, Calori G. Back pain after photodynamic therapy with verteporfin. Am J Ophthalmol. 2006;141:593-4.